Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-08-09
2009-02-17
Tsang, Cecilia (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S330000
Reexamination Certificate
active
07491703
ABSTRACT:
The invention refers to the field of medicine and can be applied as a substance capable of regulating glucose level while treating and preventing diabetes mellitus. There is proposed a biologically active new tetrapeptide lysyl-glutamyl-aspartyl-tryp-tophane of general formula Lys-Glu-Asp-Trp-NH2capable of regulating the glucose level, and pharmacological substance containing an effective amount of tetrapeptide lysyl-glutamyl-aspartyl-tryptophane of the general formula Lys-Glu-Asp-Trp-NH2. There is proposed the method of prevention and/or treatment of the diabetes mellitus, which consists in administering to a patient of the pharmacological substance, containing as an active peptide agent an effective amount of Lys-Glu-Asp-Trp-NH2tetrapeptide in doses of 0.1-30 μg/kg of the body weight at least once a day for a period necessary for attaining a therapeutic effect.
REFERENCES:
patent: 6180103 (2001-01-01), Cohen et al.
patent: 7101854 (2006-09-01), Khavinson
patent: 2004/0054130 (2004-03-01), Ng et al.
patent: 2078769 (1997-05-01), None
patent: WO 01/72770 (2001-10-01), None
Schatz et al. Why Can't We Prevent Type 1 Diabetes. Diabetes Care, Dec. 2003. vol. 26, No. 12, pp. 3326-3328.
National Diabetes Fact Sheet. http://www.cdc.gov/diabetes/pubs/general.htm accessed online Apr. 7, 2008; pp. 1-4.
Ng, FM et al.,The minimal amino acid sequence of the insulin-potentiating fragments of human growth hormone: its mechanism of action, Diabetes, vol. 29 Issue 10, pp. 782-787, 1980. (Abstract Only).
Balabolkin, M.I.,Diabetology, Mockba 2000 pp. 572-583.
Register of Pharmaceutical Substances, Acarbose pp. 58-59, Glipizide pp. 236-237, Metformin pp. 517-518, Siofor p. 759.
Grigoriev Evgeny Iosifovich
Khavinson Vladimir Khatskelevich
Malinin Vladimir Viktorovich
Ryzhak Galina Anatolievna
“Access Bioscience” CJSC
Cordero Garcia Marcela M
Leydig , Voit & Mayer, Ltd.
Tsang Cecilia
LandOfFree
Tetrapeptide regulating blood glucose level in diabetes... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrapeptide regulating blood glucose level in diabetes..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrapeptide regulating blood glucose level in diabetes... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4057453